The registration of 43.2M shares (18x current float) creates extreme near-term selling pressure. Monitor whether the company draws on the $50M ELOC facility, which would accelerate dilution. The Nasdaq compliance deadline of November 9, 2026 is a key catalyst — failure to maintain $1.00 bid price could trigger delisting and further price decline.
Executive Summary
Glucotrack filed Amendment No. 1 to its S-1 registration statement, registering up to 43,223,705 shares of common stock for resale by selling stockholders (Bridge Investors, ELOC Investor, PIPE Purchaser, September Investors). The shares represent approximately 1,825% of the current 2,368,237 shares outstanding, creating massive potential dilution. The company has a going concern warning, an accumulated deficit of ~$156.2M as of March 31, 2026, and is at risk of Nasdaq delisting if it cannot maintain a $1.00 bid price through November 9, 2026.
Key Facts
- Registration covers up to 43,223,705 shares for resale, representing ~1,825% of the 2,368,237 shares outstanding as of October 5, 2026.
- Company has a going concern warning; accumulated deficit of ~$156.2M as of March 31, 2026.
- Cash and cash equivalents were ~$3.9M as of March 31, 2026.
- Nasdaq delisting risk: must maintain $1.00 bid price through November 9, 2026, after a 1-for-15 reverse stock split on August 28, 2026.
- Company has no revenue from its CBGM or LT-100 product candidates; both are in development stages.
- Bridge Notes ($7.95M gross) were repaid in full on September 25, 2026; September Notes ($4.5M cash + debt exchange) remain outstanding.
- ELOC Purchase Agreement with White Lion Capital allows the company to sell up to $50M of stock at its discretion over three years.
- September PIPE Financing: $4.5M cash + $4.5M debt exchange for convertible notes with 8% interest, maturing June 2027.
- Registered direct offering on September 24, 2026 raised ~$3.1M gross at $2.04 per share.
- Company has 15 employees in Glucotrack Technologies (CBGM) and 9 in Lokahi (LT-100).
Financial Impact
Massive dilution: up to 43.2M new shares vs 2.37M outstanding (1,825% of float). No revenue from operations. Cash burn continues with ~$3.9M cash as of March 31, 2026.
Risk Factors
- Extreme dilution from resale of 43.2M shares (1,825% of outstanding float).
- Nasdaq delisting risk if bid price falls below $1.00 before November 9, 2026.
- Going concern uncertainty with accumulated deficit of ~$156.2M and only ~$3.9M cash.
- No approved products or revenue; both CBGM and LT-100 are in early development stages.
- Variable-rate ELOC facility could accelerate dilution if stock price declines.
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001493152-26-046915 |
| Exhibit: ex107.htm | 0001493152-26-046915 |
| Exhibit: ex5-1.htm | 0001493152-26-046915 |
| Exhibit: ex23-2.htm | 0001493152-26-046915 |
| Exhibit: ex23-3.htm | 0001493152-26-046915 |
| Document: 0001493152-26-046915-index-headers.html | 0001493152-26-046915 |
| Document: 0001493152-26-046915-index.html | 0001493152-26-046915 |
| Document: 0001493152-26-046915.txt | 0001493152-26-046915 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 5d ago | 8-K | $0.4032 | awaiting T+60 | — | $1.71 (−324.11%) |
Oct 19, 2026 8d ago | 8-K | $0.6511 | awaiting T+60 | — | $1.71 (+162.63%) |
Oct 13, 2026 13d ago | S-1/A | $0.8873 | awaiting T+60 | — | $1.71 (−92.72%) |
Oct 13, 2026 14d ago | 425 | $0.8873 | awaiting T+60 | — | $1.71 (+92.72%) |
Sep 28, 2026 29d ago | 8-K | $1.74 | awaiting T+60 | — | $1.71 (−1.72%) |
Sep 24, 2026 4w ago | 424B5 | $1.82 | awaiting T+60 | — | $1.71 (+6.04%) |
Sep 24, 2026 4w ago | 8-K | $1.82 | awaiting T+60 | — | $1.71 (+6.04%) |
Sep 23, 2026 4w ago | 425 | $2.03 | awaiting T+60 | — | $1.71 (−15.76%) |
Sep 23, 2026 4w ago | 8-K | $2.03 | awaiting T+60 | — | $1.71 (−15.76%) |
Sep 18, 2026 5w ago | 8-K | $2.30 | awaiting T+60 | — | $1.71 (−25.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers